Literature DB >> 12415080

Prostate cancer.

D Mazhar1, J Waxman.   

Abstract

It is a paradigm in cancer treatment that early detection and treatment improves survival. However, although screening measures lead to a higher rate of detection, for small bulk localised prostate cancer it remains unclear whether early detection and early treatment will lead to an overall decrease in mortality. The management options include surveillance, radiotherapy, and radical prostatectomy but there is no evidence base to evaluate the benefits of each approach. Advanced prostate cancer is managed by hormonal therapy. There have been major changes in treatment over the last two decades with the use of more humane treatment and developments in both chemotherapy and radiation. In this article we review the natural history and management of prostate cancer.

Entities:  

Mesh:

Year:  2002        PMID: 12415080      PMCID: PMC1742511          DOI: 10.1136/pmj.78.924.590

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  42 in total

Review 1.  Recent advances in the histopathology and molecular biology of prostate cancer.

Authors:  J L Burton; N Oakley; J B Anderson
Journal:  BJU Int       Date:  2000-01       Impact factor: 5.588

Review 2.  Endocrine treatment of prostate cancer - recent developments and the future. Part 1: maximal androgen blockade, early vs delayed endocrine treatment and side-effects.

Authors:  F H Schröder
Journal:  BJU Int       Date:  1999-01       Impact factor: 5.588

Review 3.  Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999.

Authors:  D G Bostwick; D J Grignon; M E Hammond; M B Amin; M Cohen; D Crawford; M Gospadarowicz; R S Kaplan; D S Miller; R Montironi; T F Pajak; A Pollack; J R Srigley; J W Yarbro
Journal:  Arch Pathol Lab Med       Date:  2000-07       Impact factor: 5.534

4.  Leuprolide versus diethylstilbestrol for previously untreated stage D2 prostate cancer. Results of a prospectively randomized trial.

Authors:  M B Garnick
Journal:  Urology       Date:  1986-01       Impact factor: 2.649

5.  The extent and multicentricity of high-grade prostatic intraepithelial neoplasia in clinically localized prostatic adenocarcinoma.

Authors:  J Qian; P Wollan; D G Bostwick
Journal:  Hum Pathol       Date:  1997-02       Impact factor: 3.466

6.  Transrectal ultrasound versus digital rectal examination for the staging of carcinoma of the prostate: results of a prospective, multi-institutional trial.

Authors:  J A Smith; P T Scardino; M I Resnick; A D Hernandez; S C Rose; M J Egger
Journal:  J Urol       Date:  1997-03       Impact factor: 7.450

7.  Carcinoma of the prostate: results of radical radiotherapy (1970-1985).

Authors:  W Duncan; P Warde; C N Catton; A J Munro; R Lakier; T Gadalla; M K Gospodarowicz
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-05-20       Impact factor: 7.038

8.  Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group.

Authors:  M V Pilepich; J M Krall; M al-Sarraf; M J John; R L Doggett; W T Sause; C A Lawton; R A Abrams; M Rotman; P Rubin
Journal:  Urology       Date:  1995-04       Impact factor: 2.649

Review 9.  Prostate-specific antigen: concepts for staging prostate cancer and monitoring response to therapy.

Authors:  H C Ruckle; G G Klee; J E Oesterling
Journal:  Mayo Clin Proc       Date:  1994-01       Impact factor: 7.616

10.  Combination finasteride and flutamide in advanced carcinoma of the prostate: effective therapy with minimal side effects.

Authors:  N E Fleshner; J Trachtenberg
Journal:  J Urol       Date:  1995-11       Impact factor: 7.450

View more
  1 in total

1.  Prostate cancer screening behaviors among Indo-Guyanese.

Authors:  Harrynauth Persaud; Jeanetta Yuan
Journal:  Cancer Causes Control       Date:  2021-11-13       Impact factor: 2.506

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.